Antibody Mediated Prevention trial: Where to from here?
04 February 2021
•
RT03
•
17:30
>
19:00
•
Antibody Mediated Prevention trial: Where to from here?
•
Live channel 1
This session is designed to unpack some of the detail on the late breaking results of the AMP trial. They will delve more deeply into how well the VRC01 antibody protected WSM and MSM from HIV acquisition and how this will inform future antibody mediated prevention trials in the future.
17:30
•
RT03.01
•
History of VRC01 – Derivation and preclinical studies
See abstract
17:40
•
RT03.02
•
Who took part in AMP and how did it go for them?
See abstract
17:50
•
RT03.03
•
Study design of AMP
See abstract
18:00
•
RT03.04
•
Relationship between ID50 and acquisition
See abstract
18:10
•
RT03.05
•
What does this mean for antibody mediated prevention in the future?
See abstract
18:20
•
RT03.06
•
Panel discussion
See abstract
|